Order of the National Green Tribunal in the matter of In Re: News Item titled "Nayar river is vanishing - a yatra reveals conservation goes beyond science and policy" appearing in ‘The Down To Earth’ dated 03.06.2025. The original application was registered suo-motu based on the news item titled "Nayar …
If the figures presented by AHIVF & Infertility Research Centre, Ranchi are to be believed then rural males associated with agriculture are facing the risk of becoming infertile due to their exposure to pesticides. The situation calls for attention as a large number of rural males are directly dependent on …
An outbreak of Ebola virus disease (EVD) has jolted West Africa, claiming more than 1000 lives since the virus emerged in Guinea in early 2014. The rapidly increasing numbers of cases in the African countries of Guinea, Liberia, and Sierra Leone have had public health authorities on high alert throughout …
Renowned Virologists and President of Nigerian Academy of Science (NAS) Prof. Oyewale Tomori Monday hinted that the much expected breakthrough in Ebola cure and vaccine may not be ready until January or February 2015. Tomori, who just returned from experts' summit on Ebola disease in Geneva, Switzerland, said necessary guidelines …
SCIENTISTS searching for new drugs to fight malaria have identified a number of compounds — some of which are currently in clinical trials to treat cancer – that could add to the anti-malarial arsenal. Duke University assistant professor Emily Derbyshire and colleagues identified more than 30 enzyme-blocking molecules, called protein …
In a significant move, the government has decided to waive off local clinical trials in case of new drugs indicated for serious, life-threatening diseases and diseases of special relevance to Indian health scenario like cancer, AIDS etc., where the likelihood of death is high. Observing that in cases of life-threatening …
China and France are jointly constructing a top-level biosafety lab in Wuhan, Hubei province, which will facilitate scientific research into dangerous viruses such as Ebola, according to French ambassador to China Sylvie Bermann. She made the remarks at the Sino-France Health Forum in Beijing on Friday, adding that the lab …
A new vaccine in its first human trials may offer protection against the chikungunya virus, a mosquito-borne infection that causes fever and severe joint pain, researchers reported Thursday in The Lancet. As of June 13, there were an estimated 166,000 suspected cases in the Caribbean and South America. Last month, …
During antiviral defense, interferon (IFN) signaling triggers nuclear transport of tyrosine-phosphorylated STAT1 (PY-STAT1), which occurs via a subset of karyopherin alpha (KPNA) nuclear transporters. Many viruses, including Ebola virus, actively antagonize STAT1 signaling to counteract the antiviral effects of IFN. Ebola virus VP24 protein (eVP24) binds KPNA to inhibit PY-STAT1 …
One of the largest big-data experiments in health care has set its first research target. The leaders of the Patient-Centered Outcomes Research Institute (PCORI) in Washington DC voted on 29 July to focus the institute’s first clinical trial on the use of aspirin to prevent heart disease. The US$10-million pilot …
“We can make a breakthrough in the field of regeneration of organs” A research being conducted on the Manonmaniam Sundaranar University (MSU) campus here on the earthworm’s regenerative capacity and its genome has attracted the attention of a researcher from the Department of Regenerative Medicine from Cedars – Sinai, the …
Taking a small daily dose of aspirin can significantly reduce the risk of developing — or dying from — bowel, stomach and oesophageal cancer, according to a large review of scientific studies.
Metabolic disorders, including obesity, diabetes, and cardiovascular disease, are widespread in Westernized nations. Gut microbiota composition is a contributing factor to the susceptibility of an individual to the development of these disorders; therefore, altering a person’s microbiota may ameliorate disease. One potential microbiome-altering strategy is the incorporation of modified bacteria …
A survey conducted by the Indian Medical Academy (IMA), a private association of doctors, across six States in the country, including Delhi, has found that 91 per cent of doctors link acid usage in toilet cleaning to long-term respiratory and other diseases. Ironically, 59 per cent of Delhiites regularly use …
AIDS researchers seeking to cure HIV with a one-two punch got an early hint the approach may work by successfully using an old cancer drug to kick the virus out of hiding in a pilot study in Denmark. Researchers from Aarhus University gave the medicine romidepsin to six HIV-infected people …
Fibroblast growth factor 1 (FGF1) is an autocrine/paracrine regulator whose binding to heparan sulphate proteoglycans effectively precludes its circulation. Although FGF1 is known as a mitogenic factor, FGF1 knockout mice develop insulin resistance when stressed by a high-fat diet, suggesting a potential role in nutrient homeostasis. Here we show that …
One in three cases of Alzheimer's disease worldwide is preventable, according to research from the University of Cambridge. The main risk factors for the disease are a lack of exercise, smoking, depression and poor education, it says. Previous research from 2011 put the estimate at one in two cases, but …
- Less for research, more for security The 2014-15 Union budget outlays for scientific research reflect marginal jumps over allocations last year with atomic energy, space, biotechnology and earth sciences among agencies earmarked hikes less than even the average inflation rate of 8 per cent. Finance minister Arun Jaitley said …
The first dengue vaccine candidate (CYDTDV) to reach phase 3 clinical testing has shown 88.5% efficacy after three doses against dengue haemorrhagic fever, according to new research published in The Lancet. Once administered CYDTDV also provided 67% protection against dengue-associated hospitalization. Researchers found that the vaccine gave low protection (35%) …
Scientists say they have developed the world's first vaccine against dengue fever seen to work in large-scale trials. Research in the Lancet journal suggests more than 50% of children who are given the vaccine are protected against the disease. Half the world's population are at risk of catching the mosquito-borne …
